Skip to content

Perioperative intensive blood pressure reduction in patients of primary intracranial hemorrhage

Perioperative intensive blood pressure reduction in patients of primary intracranial hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13004304
Enrollment
Unknown
Registered
2013-09-01
Start date
2013-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial hemorrhage

Interventions

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old and more; 2. Acute stroke syndrome due to primary intracranial haemorrhage(ICH)confirmed by CT or MRI scan, and the volume of hematoma is between 30 and 50 ml in supratentorial haemorrhage or above 10 ml in cerebellar haemorrhage; 3. GCS > 5; 4. At least two systolic blood pressure(BP) measurements of =150 mmHg and = 220mmHg, record = 5min apart; 5. Meet the indication of surgery and receive the surgery; 6. Agree to participate in this clinic trail and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Known definite indication to BP lowering treatment (e.g. very high systolic BP>220mmHg; hypertensive encephalopathy; aortic dissection); known definite contraindication to BP lowering treatment (e.g. the high BP is caused by the increasing of the intracranial pressure which is called Cushing reaction; severe cerebral or carotid stenosis, severe renal failure); 2. The intracranial haemorrhage is caused by secondary factors (e.g. arteriovenous malformation; Moya Moya disease; Anticoagulants correlation haemorrhage; tumor stroke); 3. Known definite contraindication to operation; 4. History of ischemic stroke; 5. Known advanced dementia or disability before ICH happen; 6. Concomitant medical illness that would interfere with outcome assessments and follow-up(e.g. advanced cancer; severe cardiovascular disease).

Design outcomes

Primary

MeasureTime frame
combined endpoin tof death and dependence;

Secondary

MeasureTime frame
Health related quality of life index;incidence of rebleeding;incidence of ischemic stroke;

Countries

China

Contacts

Public ContactChao You

West China Hospital, Sichuan University

youchao@vip.126.com+86 18980601505

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 28, 2026